Compounding Deal In Congress Allows Voluntary FDA Oversight Of Large-Scale Facilities

Compounders could submit to inspections, user fees and adverse event reporting, providing potential market advantage; Legislation, which includes track and trace draft bill, avoids compounding controversies and could be poised for swift passage.